Rachel J. Landauer AssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail310-228-2254 Professional Biography Rachel Landauer is an associate in the Corporate Practice Group in the firm’s Century City office and is a member of the firm’s healthcare practice team. More Legal and Business Bylines From Rachel J. Landauer In a Unanimous Vote, the Opioid Crisis Response Act of 2018 Makes it Onto the Legislative Calendar - (Posted On Wednesday, June 06, 2018) Lifting the Limits on Physician-Owned Hospitals: Can Regulators Prevail Where Legislators Have Stalled? - (Posted On Friday, March 02, 2018) Temporal Proximity Is Not Enough: Third Circuit Nixes FCA/Anti-Kickback Suit For Failure To Link Alleged Scheme to Claims - (Posted On Friday, February 09, 2018) ‘Twas the Season to Contract? A Year-End Review of Network Negotiations and Billing Disputes - (Posted On Monday, January 08, 2018) Finding Common Ground in the Healthcare Debate: Federal, State, and Local Governments Respond to the Opioid Epidemic - (Posted On Saturday, September 30, 2017) The Opportunities and Challenges of Freestanding Emergency Departments - (Posted On Wednesday, May 24, 2017) Patient Check-Ups Before Checking Out: Partnering to Bring Health Care into the “One-Stop Shopping” Sector - (Posted On Wednesday, April 19, 2017) CMS Delays Implementation of New Payment Models (Again) - (Posted On Wednesday, March 29, 2017) California HMO Timely Access Report Available - (Posted On Tuesday, March 21, 2017) Physician-Owned Hospitals: Back in Legislative Saddle Again or “I’m just a bill, I am only a bill.” - (Posted On Wednesday, March 01, 2017) Pagination Page 1 Next page Next › Current Legal Analysis Breaking Down Federal Policies to Address Drug Shortages by: McDermott + Consulting PPPlease Stop Fraud: Two Whistleblowers Awarded $2.5 Million in PPP Fraud Settlement by: Tycko & Zavareei Whistleblower Practice Group On July 1, 2024, Texas May Have the Strongest Consumer Data Privacy Law in the United States by: Elizabeth Rogers 10 Creative Ways for Lawyers to Repurpose Content by: Stefanie M. Marrone FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company by: Dominick DiSabatino , Cortney Inman Upcoming Legal Education Events Jun 26 2024 TSCA Reform — Eight Years Later Jun 18 2024 There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e) Jun 12 2024 Preparing for HHS’s 340B Administrative Dispute Resolution (“ADR”) Reboot – Lessons from the Field Jun 12 2024 Sponsor’s Role in Regulatory Testing — Complying with GLP Standards Print